Search

everythinglearnresearchcommunity

for

Search:↓

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Too much androgen can cause hair loss; finasteride may help.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Trichoscopy is a quick, noninvasive method to diagnose hair and scalp disorders, often reducing the need for biopsies.

Neurosteroids show promise for treating epilepsy and more research is needed.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Microneedling combined with triamcinolone can safely stimulate faster hair regrowth in people with Alopecia Areata.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Androgens significantly affect female hair loss, and hormonal treatments may help.